Results 61 to 70 of about 854 (148)

Intercellular redistribution of cAMP underlies selective suppression of cancer cell growth by connexin26.

open access: yesPLoS ONE, 2013
Connexins (Cx), which constitute gap junction intercellular channels in vertebrates, have been shown to suppress transformed cell growth and tumorigenesis, but the mechanism(s) still remain largely speculative.
Anjana Chandrasekhar   +5 more
doaj   +1 more source

Dominant connexin26 mutants associated with human hearing loss have trans-dominant effects on connexin30

open access: yesNeurobiology of Disease, 2010
Dominant mutations in GJB2, the gene encoding the human gap junction protein connexin26 (Cx26), cause hearing loss. We investigated whether dominant Cx26 mutants interact directly with Cx30.
Sabrina W. Yum   +2 more
doaj   +1 more source

GJB2 and GJB6 gene transcripts in the human cochlea: A study using RNAscope, confocal, and super-resolution structured illumination microscopy

open access: yesFrontiers in Molecular Neuroscience, 2022
BackgroundGap junction (GJ) proteins, connexin26 and 30, are highly prevalent in the human cochlea (HC), where they are involved in transcellular signaling, metabolic supply, and fluid homeostasis.
Wei Liu, Helge Rask-Andersen
doaj   +1 more source

The M34A mutant of Connexin26 reveals active conductance states in pore-suspending membranes

open access: yes, 2009
Connexin26 (Cx26) is a member of the connexin family, the building blocks for gap junction intercellular channels. These dodecameric assemblies are involved in gap junction-mediated cell-cell communication allowing the passage of ions and small molecules
Kreir, Mohamed   +8 more
core   +1 more source

Hypothesis of K+-Recycling Defect Is Not a Primary Deafness Mechanism for Cx26 (GJB2) Deficiency

open access: yesFrontiers in Molecular Neuroscience, 2017
K+-recycling defect is a long-standing hypothesis for deafness mechanism of Connexin26 (Cx26, GJB2) mutations, which cause the most common hereditary deafness and are responsible for >50% of nonsyndromic hearing loss.
Hong-Bo Zhao
doaj   +1 more source

Gap junction mediated intercellular metabolite transfer in the cochlea is compromised in connexin30 null mice. [PDF]

open access: yesPLoS ONE, 2008
Connexin26 (Cx26) and connexin30 (Cx30) are two major protein subunits that co-assemble to form gap junctions (GJs) in the cochlea. Mutations in either one of them are the major cause of non-syndromic prelingual deafness in humans. Because the mechanisms
Qing Chang   +4 more
doaj   +1 more source

Studies of intercellular Ca2+ signaling and gap-junction coupling in the developing cochlea of mouse models affected by congenital hearing loss [PDF]

open access: yes, 2013
Connexin 26 (Cx26) and connexin 30 (Cx30) form gap junction channels that allow the intercellular diffusion of the Ca2+ mobilizing second messenger IP3.
Rodriguez Hernandez, Laura
core  

Inner ear cell therapy targeting hereditary deafness by activation of stem cell homing factors

open access: yesFrontiers in Pharmacology, 2015
Congenital deafness affects about 1 in 1000 children and more than half of them have a genetic background such as Connexin26 (CX26) gene mutation. Inner ear cell therapy for sensorineural hearing loss has been expected to be an effective therapy for ...
Kazusaku eKamiya
doaj   +1 more source

Deficiency of transcription factor Brn4 disrupts cochlear gap junction plaques in a model of DFN3 non-syndromic deafness. [PDF]

open access: yesPLoS ONE, 2014
Brn4, which encodes a POU transcription factor, is the gene responsible for DFN3, an X chromosome-linked, non-syndromic type of hearing loss. Brn4-deficient mice have a low endocochlear potential (EP), hearing loss, and ultrastructural alterations in ...
Yoshinobu Kidokoro   +6 more
doaj   +1 more source

Immunoprofiles of 11 Biomarkers Using Tissue Microarrays Identify Prognostic Subgroups in Colorectal Cancer

open access: yesNeoplasia: An International Journal for Oncology Research, 2005
BACKGROUND, AIMS: Genomewide expression profiling has identified a number of genes expressed at higher levels in colorectal cancer (CRC) than in normal tissues. Our objectives in this study were: 1) to test whether genes were also distinct on the protein
Thomas Knösel   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy